Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MYM Nutraceuticals Inc MYMMF

Healthcare Drug Manufacturers - Major
MYM Nutraceuticals Inc is a Canada based company engaged in the business of acquiring and developing natural remedies. The company is focused on the medical marijuana business by producing cannabis growing facilities and products.


GREY:MYMMF - Post by User

MYM Nutraceuticals Inc > See you later @0.05
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(6)
•••
Comment by kalaretaon Jan 24, 2020 2:39pm
193 Views
Post# 30595904

RE:See you later @0.05

RE:See you later @0.05I had a good laugh . You know why. I had this stock before at 0.05 c and sold for only 0.30 c because of people on this board. They were constantly saying how bad this company is etc,,. Now I am in at 0.07 again and will wait this time, 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities